Cargando…
Pharmacology of Ramelteon, a Selective MT(1)/MT(2) Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders
An estimated one‐third of the general population is affected by insomnia, and this number is increasing due to more stressful working conditions and the progressive aging of society. However, current treatment of insomnia with hypnotics, gamma‐aminobutyric acid A (GABA(A)) receptor modulators, induc...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871175/ https://www.ncbi.nlm.nih.gov/pubmed/19228178 http://dx.doi.org/10.1111/j.1755-5949.2008.00066.x |